PIGN
GPI ethanolamine phosphate transferase 1
Also known as: MCD4, PIG-N, PIGN_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O95427
- Gene
- PIGN
- Ensembl
- ENSG00000197563
- Chromosome
- 18
- Canonical length
- 931 aa
- Protein class
- Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Plasma membrane,Cytosol
OverviewNCBI Gene
This gene encodes a protein that is involved in glycosylphosphatidylinositol (GPI)-anchor biosynthesis. The GPI-anchor is a glycolipid found on many blood cells and serves to anchor proteins to the cell surface. This protein is expressed in the endoplasmic reticulum and transfers phosphoethanolamine (EtNP) to the first mannose of the GPI anchor. Two alternatively spliced variants, which encode an identical isoform, have been reported. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
931 residues, UniProt reviewed canonical sequence.
>O95427|PIGN
1 MLLFFTLGLL IHFVFFASIF DIYFTSPLVH GMTPQFTPLP PPARRLVLFV ADGLRADALY
61 ELDENGNSRA PFIRNIIMHE GSWGISHTRV PTESRPGHVA LIAGFYEDVS AVAKGWKENP
121 VEFDSLFNES KYTWSWGSPD ILPMFAKGAS GDHVYTYSYD AKREDFGAQD ATKLDTWVFD
181 NVKDFFHHAR NNQSLFSKIN EEKIVFFLHL LGIDTNGHAH RPSSRDYKHN IKKVDDGVKE
241 IVSMFNHFYG NDGKTTFIFT SDHGMTDWGS HGAGHPSETL TPLVTWGAGI KYPQRVSAQQ
301 FDDAFLKEWR LENWKRLDVN QADIAPLMTS LIGVPFPLNS VGILPVDYLN NTDLFKAESM
361 FTNAVQILEQ FKVKMTQKKE VTLPFLFTPF KLLSDSKQFN ILRKARSYIK HRKFDEVVSL
421 CKELIHLALK GLSYYHTYDR FFLGVNVVIG FVGWISYASL LIIKSHSNLI KGVSKEVKKP
481 SHLLPCSFVA IGILVAFFLL IQACPWTYYV YGLLPLPIWY AVLREFQVIQ DLVVSVLTYP
541 LSHFVGYLLA FTLGIEVLVL SFFYRYMLTA GLTAFAAWPF LTRLWTRAKM TSLSWTFFSL
601 LLAVFPLMPV VGRKPDISLV MGAGLLVLLL SLCVVTSLMK RKDSFIKEEL LVHLLQVLST
661 VLSMYVVYST QSSLLRKQGL PLMNQIISWA TLASSLVVPL LSSPVLFQRL FSILLSLMST
721 YLLLSTGYEA LFPLVLSCLM FVWINIEQET LQQSGVCCKQ KLTSIQFSYN TDITQFRQLY
781 LDDIRRAFFL VFFLVTAFFG TGNIASINSF DLASVYCFLT VFSPFMMGAL MMWKILIPFV
841 LVMCAFEAVQ LTTQLSSKSL FLIVLVISDI MALHFFFLVK DYGSWLDIGT SISHYVIVMS
901 MTIFLVFLNG LAQLLTTKKL RLCGKPKSHF MLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PIGN can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 15
- Mean surface accessibility (rSASA)
- 0.24
- Highest tissue expression
- 21 nTPM
Expression across tissuesHPA
Tissue
- retina: 21 nTPM
- esophagus: 20 nTPM
- stomach: 17 nTPM
- rectum: 16 nTPM
- skin: 16 nTPM
- testis: 15 nTPM
Single-cell type
- prostatic glandular cells: 241 nCPM
- choroid plexus epithelial cells: 169 nCPM
- esophageal apical cells: 154 nCPM
- lacrimal acinar cells: 145 nCPM
- gonadotrophs: 142 nCPM
- oligodendrocytes: 137 nCPM
Immune cell
- NK-cell: 11 nTPM
- myeloid DC: 8.3 nTPM
- plasmacytoid DC: 8.1 nTPM
- naive CD8 T-cell: 7 nTPM
- non-classical monocyte: 6.9 nTPM
- naive B-cell: 6.7 nTPM
Brain region
- cerebellum: 173 nTPM
- cerebral cortex: 168 nTPM
- white matter: 168 nTPM
- hypothalamus: 139 nTPM
- amygdala: 131 nTPM
- basal ganglia: 131 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about PIGN.
Disease | AllUniProt
Conditions PIGN is implicated in, by any mechanism.
- Multiple congenital anomalies-hypotonia-seizures syndrome 1 (MCAHS1) MIM:614080
Disease | GeneticClinVar
187 pathogenic / likely-pathogenic of 1,390 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Multiple congenital anomalies-hypotonia-seizures syndrome 1
- Inborn genetic diseases
- Multiple congenital anomalies-hypotonia-seizures syndrome
- Fetal anomalies with a likely genetic cause
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.02
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.42
- DepMap mean gene effect
- -0.06
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Type I phosphodiesterase/nucleotide pyrophosphatase/phosphate transferase
- Alkaline-phosphatase-like, core domain superfamily
- Type I phosphodiesterase / nucleotide pyrophosphatase
- GPI ethanolamine phosphate transferase 1
- GPI ethanolamine phosphate transferase 1, C-terminal
- GPI ethanolamine phosphate transferase 1, N-terminal
- Phosphatidylinositolglycan class N (PIG-N)
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PIGN as an antibody target. Whether an autoantibody or antibody against PIGN could matter depends on whether native PIGN is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PIGN is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PIGN as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...